multiple sclerosis
"I was using Copaxone for years and switched to Glatopa a few months ago. I have not had any negative effects with Glatopa. I have great insurance so cost didn't drive my decision to switch. I just would like to see Teva go out of business for over charging AND stifling healthy competition that leads to innovative breakthroughs. 
I haven't notice any less effectiveness with Glatopa and I would because when I have a flair up, it's usually in the form of optic neuritis. 
Now that that  Teva strangle hold on Copaxone generics in the United States is no longer, I'm hoping that other big pharma vendors get into manufacturing high quality Copaxone generics and even develop more highly effective MS treatments."